Merck Strikes Damages Deal In Fosamax Bellwether Case

Law360, New York (September 18, 2012, 1:32 PM EDT) -- Merck & Co. Inc. has reached a confidential damages agreement in New York federal court with the estate of a Florida woman whose $8 million jury verdict in jawbone-death litigation over osteoporosis drug Fosamax was later overturned, an attorney for the plaintiff said Tuesday.

Timothy M. O'Brien, a lawyer for the estate of Shirley Boles, said the parties had reached a confidential stipulation on damages, which a Merck spokesman emphasizes is not a settlement, on Sept. 8. Boles won an $8 million jury verdict in June...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Boles v. Merck & Co., Inc.


Case Number

1:06-cv-09455

Court

New York Southern

Nature of Suit

Personal Inj. Prod. Liability

Judge

John F. Keenan

Date Filed

October 17, 2006

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.